BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21355312)

  • 1. [Co-transplantation of myoblasts and schwann cells in the therapy of Duchenne muscular dystrophy].
    Luo L; Zhou HY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):101-5. PubMed ID: 21355312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy.
    Qu Z; Huard J
    Gene Ther; 2000 Mar; 7(5):428-37. PubMed ID: 10694825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental study of treating Duchenne muscular dystrophy with myoblast transplantation].
    Liu L; Zhou H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Oct; 23(10):1224-8. PubMed ID: 19957845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise improves the success of myoblast transplantation in mdx mice.
    Bouchentouf M; Benabdallah BF; Mills P; Tremblay JP
    Neuromuscul Disord; 2006 Aug; 16(8):518-29. PubMed ID: 16919954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystrophin expression following the transplantation of normal muscle precursor cells protects mdx muscle from contraction-induced damage.
    Rousseau J; Dumont N; Lebel C; Quenneville SP; Côté CH; Frenette J; Tremblay JP
    Cell Transplant; 2010; 19(5):589-96. PubMed ID: 20650035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of Dystrophin Expressing Chimeric Human Cells of Myoblast/Mesenchymal Stem Cell Origin Improves Function in Duchenne Muscular Dystrophy Model.
    Siemionow M; Szilagyi E; Cwykiel J; Domaszewska-Szostek A; Heydemann A; Garcia-Martinez J; Siemionow K
    Stem Cells Dev; 2021 Feb; 30(4):190-202. PubMed ID: 33349121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector.
    Bujold M; Caron N; Camiran G; Mukherjee S; Allen PD; Tremblay JP; Wang Y
    Cell Transplant; 2002; 11(8):759-67. PubMed ID: 12588108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
    Lala-Tabbert N; Fu D; Wiper-Bergeron N
    Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Losartan enhances the success of myoblast transplantation.
    Fakhfakh R; Lamarre Y; Skuk D; Tremblay JP
    Cell Transplant; 2012; 21(1):139-52. PubMed ID: 21535912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystrophin expression in host muscle following transplantation of muscle precursor cells modified with the phiC31 integrase.
    Quenneville SP; Chapdelaine P; Rousseau J; Tremblay JP
    Gene Ther; 2007 Mar; 14(6):514-22. PubMed ID: 17167499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The survival of myoblasts after intramuscular transplantation is improved when fewer cells are injected.
    Pellegrini KL; Beilharz MW
    Transplantation; 2011 Mar; 91(5):522-6. PubMed ID: 21192317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.
    Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS
    Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation.
    Kinoshita I; Huard J; Tremblay JP
    Muscle Nerve; 1994 Sep; 17(9):975-80. PubMed ID: 8065399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice.
    Mueller GM; O'Day T; Watchko JF; Ontell M
    Hum Gene Ther; 2002 Jun; 13(9):1081-90. PubMed ID: 12067441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
    Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
    Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin gel improves the survival of transplanted myoblasts.
    Gerard C; Forest MA; Beauregard G; Skuk D; Tremblay JP
    Cell Transplant; 2012; 21(1):127-37. PubMed ID: 21535909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin.
    Li S; Kimura E; Fall BM; Reyes M; Angello JC; Welikson R; Hauschka SD; Chamberlain JS
    Gene Ther; 2005 Jul; 12(14):1099-108. PubMed ID: 15759015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
    Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved success of myoblast transplantation in mdx mice by blocking the myostatin signal.
    Benabdallah BF; Bouchentouf M; Tremblay JP
    Transplantation; 2005 Jun; 79(12):1696-702. PubMed ID: 15973171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells.
    Payne TR; Oshima H; Sakai T; Ling Y; Gharaibeh B; Cummins J; Huard J
    Gene Ther; 2005 Aug; 12(16):1264-74. PubMed ID: 15843810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.